Aktionsplan 3SBio Inc.
Über das Unternehmen 3SBio Inc.
3SBio Inc., инвестиционная холдинговая компания, разрабатывает, производит и продает биофармацевтические продукты в материковом Китае и за рубежом. weitere detailsIPO date | 2007-02-07 |
---|---|
ISIN | KYG8875G1029 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | hkd |
Валюта отчета | cny |
Див.доход ао | 3.94 |
Дивиденд ао | 0.25 |
Сайт | https://www.3sbio.com |
Цена ао | 10.56 |
Preisänderung pro Tag: | +7.21% (9.85) |
---|---|
Preisänderung pro Woche: | +16.94% (9.03) |
Preisänderung pro Monat: | +60.24% (6.59) |
Preisänderung über 3 Monate: | +73.11% (6.1) |
Preisänderung über sechs Monate: | +85.26% (5.7) |
Preisänderung pro Jahr: | +94.48% (5.43) |
Preisänderung über 3 Jahre: | +120.46% (4.79) |
Preisänderung über 5 Jahre: | -0.565% (10.62) |
Preisänderung seit Jahresbeginn: | +75.42% (6.02) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Institutionen | Volumen | Aktie, % |
---|---|---|
Vanguard International Stock Index-Total Intl Stock Indx | 24919141 | 1.02 |
Vanguard International Stock Index-Emerging Markets Stk | 24705586 | 1.01 |
iShares Core MSCI Emerging Markets ETF | 14806500 | 0.61 |
DFA Emerging Markets Core Equity Portfolio | 12727500 | 0.52 |
iShares ESG Aware MSCI EM ETF | 10342500 | 0.42 |
DFA Investment Dimensions-DFA Emerging Mkts Value | 5535500 | 0.23 |
DFA Emerging Markets Small Cap Series | 5451500 | 0.22 |
iShares MSCI China ETF | 5444500 | 0.22 |
Old Westbury Small & Mid Cap Strategies Fund | 5415716 | 0.22 |
iShares MSCI Emerging Markets ETF | 4857000 | 0.2 |
ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
---|---|---|---|
Vident International Equity Strategy ETF | 0.42978 | 6.83 | 5.52154 |
Franklin FTSE China ETF | 0.06824 | 14.5 | 3.35323 |
JPMorgan Diversified Return Emerging Markets Equity ETF | 0.06375 | 7.2 | 5.1761 |
WisdomTree Emerging Markets SmallCap Dividend Fund | 0.059 | 1.35 | 5.00999 |
Goldman Sachs Innovate Equity ETF | 0.05885 | 29.66 | 1.20987 |
Dimensional Emerging Markets Value ETF | 0.05803 | 17.07 | 4.19508 |
Dimensional Emerging Markets Core Equity 2 ETF | 0.04377 | 15.96 | 3.34087 |
Avantis Responsible Emerging Markets Equity ETF | 0.04179 | 17.6 | 3.1719 |
![]() |
0.03602 | 17.02 | 3.40103 |
Avantis Emerging Markets Equity ETF | 0.03511 | 8.77 | 3.60513 |
Franklin FTSE Asia ex Japan ETF | 0.01535 | 14.43 | 2.66768 |
Dimensional World ex U.S. Core Equity 2 ETF | 0.01413 | 13.06 | 3.62488 |
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.0137 | 12.46 | 3.59676 |
Vanguard ESG International Stock ETF | 0.01 | 6.39 | 3.07501 |
SPDR Portfolio Emerging Markets ETF | 0.00877 | 11.59 | 3.1879 |
0.06 | 12.93 | 3.61 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Dr. Jing Lou M.D., Ph.D. | Co-Founder, Executive Chairman, CEO & President | 4.85M | 1963 (62 Jahr) |
Dr. Dongmei Su | Senior VP & Executive Director | 1.53M | 1970 (55 Jahre) |
Ms. Siu Kuen Lai FCIS, FCS | Company Secretary | N/A | 1976 (49 Jahre) |
Zhao Xinyi | Executive of IR | N/A | |
Mr. Xiang He | Chief Financial Officer | N/A | 1984 (41 Jahr) |
Adresse: China, Shenyang, No. 3 A1 Road 10 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.3sbio.com
Webseite: https://www.3sbio.com